Clinical Trial Update: HMPL-760 in Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 study of HMPL-760 in relapsed/refractory B-cell non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• HMPL-760

Snippet

Sponsor: Hutchmed | Conditions: B-Cell Non-Hodgkin's Lymphoma | Phase 1 | Status: COMPLETED